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AbstrACt
Objectives Asthma has not been extensively studied in 
low- income and middle- income countries, where risk 
factors and access to treatment may differ from more 
affluent countries. We aimed to identify the prevalence of 
asthma and local risk factors in Havana, Cuba.
setting Four municipalities in Havana, Cuba.
Participants A population- based cohort study design 
of young children living in Havana, Cuba. Children were 
recruited from primary care centres at age 12–15 months.
Primary and secondary outcome measures Data on 
wheeze in the past 12 months, asthma treatment and 
environmental exposures collected regularly until the age 
of 6 years, when forced expiratory volume in 1 s (FEV
1) and 
reversibility to aerosolised salbutamol were also measured.
results 1106 children provided data at the age of 6 years 
old. The prevalence of wheeze in the previous 12 months 
was 422 (38%), and 294 (33%) of the study population 
had bronchodilatation of 12% or more in FEV
1 after 
administration of inhaled salbutamol. In the previous 12 
months, 182 (16%) of the children had received inhaled 
corticosteroids, 416 (38%) salbutamol inhalers and 283 
(26%) a course of systemic steroids.
Wheeze in the first year and a family history of asthma 
were both positively associated with bronchodilatation 
to inhaled salbutamol (1.94%; 95% CI 0.81 to 3.08 and 
1.85%; CI 0.14 to 3.57, respectively), while paracetamol 
use in the first year was associated with wheeze at 6 
years (OR 1.64, 95% CI 1.14 to 2.35). There were large 
differences in FEV
1, bronchodilatation and risk of wheeze 
across different geographical areas.
Conclusions Asthma is common in young children living 
in Havana, and the high prevalence of systemic steroids 
administrated is likely to reflect the underuse of regular 
inhaled corticosteroids. If replicated in other comparable 
low- income and middle- income countries, this represents 
an important global public health issue.
IntrOduCtIOn
Asthma is a global disease that affects approx-
imately 11% of 6- year- old children,1 but with 
marked regional differences in prevalence.1 
The aetiology of asthma is complex, and 
involves a range of environmental exposures 
that are likely to have differential impacts at 
different ages over the human lifetime.2–7 
The early years of childhood is a particularly 
important period as this is when the lungs 
and immune system are developing rapidly, 
and lung function in children is a key deter-
minant of health in adulthood.8
This study was established as a consequence 
of concerns among public health specialists 
and clinicians that asthma was becoming a 
large problem in Cuba. It aimed to determine 
the prevalence of wheeze in young children 
living in Cuba, and to identify modifiable risk 
factors for wheezing, reduced lung function 
and reversible bronchoconstriction. The role 
of infection in early life in the development 
strengths and limitations of this study
 ► There have been many epidemiological studies of 
asthma in children who live in developed countries, 
but few population- based studies that have used 
objective measures of asthma in low- income and 
middle- income countries.
 ► The prevalence of bronchoconstriction in young 
children living in Havana was measured using both 
subjective and objective measures of asthma.
 ► Life course exposure data were available from birth 
onwards.
 ► Data on lung development were objectively mea-
sured using spirometry.
 ► These data are from one low- income and middle- 
income countries and thus not generalisable to oth-
er nations with different economies and healthcare 
systems.
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Figure 1 Flow diagram of participants and data collection.
of allergic disease remains unclear.9 The main hypothesis 
of interest was that infection with parasites,10 Helicobacter 
pylori,11 dengue12 or systemic inflammation13 may be asso-
ciated with wheeze or bronchoconstriction. Exposure 
to environmental tobacco smoke and paracetamol had 
previously been observed to be positively associated with 
wheeze14 or atopic dermatitis15 symptoms, respectively, 
and so the association of these exposures with wheeze and 
bronchoconstriction were also studied. Finally, as growth 
from in utero onwards may also be related to development 
of asthma and growth of the lungs,16 anthropometric 
measures from birth onwards were also considered. The 
study design is a prospective population- based study of an 
existing cohort of children followed from approximately 
1 year of age for 5 years.
MethOds
study population and sample collection
The study population is a cohort of 1956 children aged 
12–15 months who were randomly selected from the 
general population from four municipalities across 
Havana in 2010 and 2011.14 15 17 The response rate of those 
who were eligible to participate initially was 96%.14 Data 
were collected by a standardised questionnaire that was 
administered by a member of the study team at baseline 
and subsequently at 2 years, 3 years and 5 years later. This 
included a number of health and lifestyle questions that 
were answered by the parent or guardian and particular 
attention was paid to parental/guardian reported wheeze 
in the past 12 months using the methodology developed 
for the ISAAC epidemiological studies of asthma,18 use of 
asthma medication in the past 12 months and exposure to 
environmental tobacco smoke. The child’s weight, height 
and mid- arm circumference in both arms were collected 
at each study visit. Historical baseline data including 
birth weight and height were collected from the primary 
care centre records. At each annual follow- up study 
the participants’ guardians were asked if the child had 
received a medical diagnosis of dengue infection in the 
previous year (in Cuba all positive diagnoses of dengue 
infection are clinically confirmed using a serological IgM 
assay) and a blood sample was collected from children 
to measure circulating eosinophil levels. This sample was 
stored at −20°C and subsequently defrosted and analysed 
for dengue IgG serology to generate an antibody index,19 
serum IgE,17 highly sensitive C- reactive protein (hsCRP, 
SpinReact, Spain),20 toxoplasmosis IgG antibodies21 
and toxocariasis IgG antibodies (DRG Instruments, 
Germany). A faecal sample was also collected at each 
review and stored at −20°C, and later examined for H. 
pylori using the faecal antigen test (SpinReact, Spain) and 
intestinal parasites using the Kato- Katz test (Campiñas 
Medical COMI, Brazil).
Lung function
Forced expiratory volume in 1 s (FEV1) and forced vital 
capacity were measured in accordance with American 
Thoracic Society/European Respiratory Society criteria22 
using spirometers (CareFusion Micro I) calibrated each 
day to allow for local climatic change. The best value of 
FEV1 within a threshold of repeatability of 200 mL was 
used as the final value. Aerosolised salbutamol (300 µg) 
was then administered via a spacer and after 15- min lung 
function was measured again to quantify airway revers-
ibility. In children who provided a postbronchodilator 
FEV1 that was less than the baseline value, they were 
considered as having no reversibility to bronchodilator as 
this was likely to be due to fatigue.
Allergen skin prick testing
Skin prick testing was used to determine allergy to mite, 
cat, grass, cockroach, fungus, mosquitos, wheat and soy 
(allergens from Diater, Argentina except mite allergen 
from Biocen, Cuba). For each test a drop of allergen solu-
tion was placed on the skin and a lancet used to break 
the skin. After 15 min, the skin weal was measured at 
its maximum diameter, and also perpendicularly, and 
a mean value generated. The final skin prick test result 
was calculated by subtracting the saline result from the 
allergen. A value of ≥3 mm was used to define a positive 
atopic result for each allergen, and atopy was defined as 
any positive skin prick test.
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Figure 2 Histogram of per cent increase in forced expiratory 
volume in 1 s (FEV1) in study population (n=903 children).
statistical analysis
The main outcome variables were FEV1, per cent increase 
in FEV1 after to inhaled salbutamol and wheeze in the past 
12 months. The main exposure variables were grouped 
into three categories:
1. Prior exposures: wheeze in the first year of life, fami-
ly history of asthma, nursery attendance, birth weight, 
birth height, duration of breastfeeding, blood IgE and 
eosinophils at 1 year old; faecal H. pylori antigen at 2 
and 3 years old; blood hsCRP, dengue IgG serology, 
eosinophils, toxoplasmosis serology, IgE at 3 years old 
and any prior medical diagnosis of dengue infection.
2. Cross- section exposures: number of smokers living in 
the home, current weight, current height, mean arm 
circumference, municipality of residence.
3. Biomarkers of current infection and inflammation: H. 
pylori stool antigen, toxoplasmosis IgG serology, den-
gue IgG serology, blood hsCRP, eosinophils, IgE, toxo-
cariasis serology and atopy. Less than 2% of children 
has current gastro- intestinal parasite infection and 
these data were not analysed further.
Statistical analysis used linear and logistic regression 
adjusting for sex and age in months as a priori confounding 
factors, and also adjusted for clustering by municipality of 
residence. As height was associated with FEV1, all anal-
yses of this outcome measure also adjusted for height to 
ensure that the analyses were not confounded by somatic 
growth. χ2 tests were used to explore differences in cate-
gorical exposures for binary outcome measures. All anal-
yses used Stata V.14 statistical software.
Patient and public involvement
The study was designed as a consequence of concerns 
from the Cuban public health and clinical communities 
about asthma morbidity. The patients were not involved 
in the design of the study and patients did not receive a 
copy of the results. We thank the patients and their fami-
lies for their participation.
Consent on the behalf of the child was provided by the 
attending parent or guardian.
resuLts
Data were available for 1106 children, of whom 422 (38%) 
had reported wheeze in the previous year (figure 1). 
Wheeze in the first year of life was reported in 514 (46%) 
current participants, while there was a prevalence of 
wheeze in the first year of life of 42% (358 children) for 
those who did not participate in the study at the age of 6 
years (p=0.055). Nine hundred and thirteen (83%) chil-
dren provided lung function data, and of these 903 (99%) 
children had their reversibility to salbutamol measured. 
The mean FEV1 was 1.13 L (SD 0.31), and 294 (33%) had 
an increase in FEV1 of more than 12% after administra-
tion of aerosolised salbutamol (figure 2). Two hundred 
and eighty- three (26%) of the current study population 
were reported to have received systemic steroids in the 
previous 12 months (table 1).
risk factors for wheeze in the past 12 months at 6 years old
The analysis of the association of exposures with wheeze 
in the past 12 months is presented in table 2. Both wheeze 
(OR 1.89; 95% CI 1.65 to 2.16) and paracetamol use (OR 
1.64; 95% CI 1.14 to 2.35) in the first year of life along with 
a family history of asthma (OR 1.66; 95% CI 1.40 to 1.97) 
were associated with wheeze at 6 years. A positive H. pylori 
faecal antigen test at age 2 years was negatively associated 
with wheeze in the past 12 months (OR 0.57; 95% CI 0.40 
to 0.82), but this association was not observed for H. pylori 
at the age of 3 years or 6 years. The number of smokers 
in the household was a strong risk factor for wheeze in 
the past 12 months (p<0.001 for trend), with homes with 
two or more smokers having an OR of the child having 
wheeze in the past 12 months of 2.08 (95% CI 1.71 to 
2.54) compared with those homes with no smokers. The 
municipality of residence was associated with wheeze in 
the past 12 months (p=0.04, χ2 test), with children living 
in Cerro municipality having the highest risk of wheeze 
(OR 1.72 compared with Arroyo Naranjo; 95% CI 1.61 to 
1.84). These differences were not substantially modified 
by adjusting for the number of smokers in the home.
risk factors for decreased FeV1 at 6 years old
The analysis of the association of a number of exposures 
with FEV1 is presented in table 3. A number of measures 
of somatic growth were positively associated with FEV1 at 
6 years. These were birth height (14 mL /cm height at 
birth; 95% CI 6 to 23), current height (11 mL /cm; 95% 
CI 5 to 18), current weight (11 mL /kg; 95% CI 3 to 18) 
and current mean arm circumference (12 mL /cm; 95% 
CI 1 to 24). The number of smokers living in the home 
was not associated with lung function, but the munic-
ipality of residence was strongly associated with current 
FEV1 (p<0.001, Ananlysis of Variance/ANOVA test), with 
children living in La Lisa having the lowest lung function 
(−95 mL compared with Arroyo Naranjo, 95% CI −126 to 
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Table 1 Description of study population
Total (n=1106)
Provided FEV1 
(n=913)
Male sex (%) 575 (52) 473 (52)
Mean age, months 
(range)
74 (63– 83) 74 (64 –83)
Mean FEV1, L, (SD) – 1.13 (0.31)
Mean 
bronchodilation after 
salbutamol, % (SD)
– 13.4 (20.1)
n=903
Wheeze in the past 
12 months (%)
422 (38) 356 (39)
Received inhaled 
steroids in the 12 
months before (%)
    
  Year 1 89 (8) 68 (7)
  Year 2 176 (17) n=1051 153 (18) n=869
  Year 3 203 (18) 163 (18)
  Year 4 – –
  Year 5 182 (16) 150 (16)
Received 
salbutamol inhaler 
in the previous 12 
months (%)
    
  Year 5 416 (38) 345 (38)
Received 
intravenous or oral 
steroids in the 12 
months before (%)
    
  Year 1 295 (27) 244 (27)
  Year 2 418 (40) n=1051 345 (40) n=869
  Year 3 407 (37) 333 (36)
  Year 4 – –
  Year 5 283 (26) 240 (26)
FEV1, forced expiratory volume in 1 s.
−64). These differences were not substantially modified 
by adjusting for the number of smokers in the home. No 
measures of infection or inflammation were associated 
with lung function.
risk factors for bronchodilatation after inhaled salbutamol at 
6 years old
The association of exposures with change in FEV1 from 
baseline after aerosolised salbutamol was administered is 
presented in table 4. Any wheeze in the first year of life 
was positively associated with bronchodilatation (1.94%; 
95% CI 0.81 to 3.08) as was a family history of asthma 
(1.85; 95% CI 0.14 to 3.57), but there was no relation 
with wheeze in the past 12 months (3.61; 95% CI −5.80 
to 13.02). Children with a higher birth weight had a 
lower risk of bronchodilatation (–2.67%; 95% CI −4.49 
to −0.84). IgE at the age of 1 year was positively associated 
with a higher risk of bronchodilatation (1.68%; 95% CI 
0.54 to 2.82), but not IgE at age of 3 years or 6 years.
The numbers of smokers living in the child’s home was 
not associated with bronchodilation, but the municipality 
of residence was again a strong determinant of current 
bronchodilatation (p=0.002, ANOVA test), with children 
living in La Lisa having the highest increase in FEV1 
after administration of inhaled salbutamol at 6 years old 
(6.24% compared with Arroyo Naranjo; 95% CI 5.56 to 
6.91). These differences were not substantially modified 
by adjusting for the number of smokers in the home.
dIsCussIOn
The most striking observation from our cohort study of 
young children living in Havana is that the prevalence of 
wheeze in these children was high, with 38% reporting 
wheeze in the past 12 months. Similarly, there was a high 
prevalence of bronchoconstriction using the objective 
measure of lung function reversibility to inhaled salbu-
tamol, with 33% of the study population having an 
increase in FEV1 of 12% or more. Over a quarter of these 
6 years old children have received systemic steroids in 
the previous 12 months, suggesting that asthma control 
was suboptimal. The main consistent association is that 
municipality of residence is a strong risk factor for wheeze, 
low lung function and bronchoconstriction. A history of 
wheeze in early life, exposure to paracetamol in the first 
year of life and current environmental tobacco smoke 
were risk factors for wheeze, anthropometric measures 
were positively associated with higher FEV1, and wheeze 
in the first year of life and lower birth weight were associ-
ated with untreated bronchoconstriction.
strengths and limitations of the data
This is the first cohort study of young children living 
in Cuba that has collected extensive life course data to 
evaluate risk factors for asthma using objective measures 
of lung function and reversibility along with laboratory 
measures of exposure to infection. The strengths of our 
data include the prospective nature of the data collected 
with exposures and outcome measures that were selected 
to permit exploration of risk factors for asthma specifically 
within an urban Cuban environment, where the lifestyle, 
environment and microbial exposures are very different 
to more temperate, developed countries. The measure-
ment of lung function is a challenge in young children, 
yet measurements were obtained in 82% of eligible chil-
dren. The availability of lung function measurements 
along with reversibility to inhaled salbutamol is a partic-
ular strength of these data, as it provides an objective 
measure that may reflect different aspects of lung health 
compared with self- reported symptoms.
Our dataset does have some limitations. We initially 
recruited 1956 children to the cohort at the age of 1 
year with a response rate of 96% eligible children, and 
approximately 5 years later were able to collect data on 
1106 (57%) of these. This was mainly a consequence of 
 o
n
 April 29, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-034192 on 22 April 2020. Downloaded from 
5Suárez- Medina R, et al. BMJ Open 2020;10:e034192. doi:10.1136/bmjopen-2019-034192
Open access
Table 2 Association of exposures with wheeze in past 12 months
Total number=1106 No (%, SD) OR of wheeze (95% CI)
Prior exposures
Any wheeze in first year of life 514 (46) 1.89 (1.65 to 2.16)
Family history of asthma 614 (56) 1.66 (1.40 to 1.97)
Attendance at nursery 159 (14) 0.84 (0.57 to 1.24)
Paracetamol in first year of life 256 (23) 1.64 (1.14 to 2.35)
Mean birth weight, N, kg (SD) n=1104 3.31 (0.51) 0.87 (0.75 to 1.01)
Mean birth height, cm (SD) 50.2 (2.4) 0.95 (0.89 to 1.00)
Breast feeding ≥4 months 608 (55) 0.83 (0.66 to 1.03)
Age=1 year
Mean log IgE, n=885 3.38 (1.47) 1.06 (0.88 to 1.27)
Mean log eosinophils, n=856 −2.11 (1.05) 0.93 (0.77 to 1.13)
Age=2 years
Helicobacter stool +ve, n=1067 40 (4) 0.57 (0.40 to 0.82)
Age=3 years
Mean log CRP, SD, n=986 −2.07 (2.70) 1.01 (0.95 to 1.07)
Log dengue IgG, n=865 −0.44 (2.00) 0.99 (0.96 to 1.02)
Helicobacter stool +ve, n=951 58 (6) 1.01 (0.64 to 1.60)
Mean log eosinophils, n=1039 −1.77 (1.23) 0.91 (0.86 to 0.96)
Toxoplasmosis serology +ve, n=966 565 (58) 1.15 (0.82 to 1.64)
Mean log IgE, n=986 3.70 (1.53) 1.14 (0.98 to 1.31)
Medical diagnosis of dengue infection 93 (8) 1.40 (0.91 to 2.14)
Current exposures
Male sex 575 (52) 1.35 (1.00 to 1.82)
Age (months), (range) 74 (63 to 83) 0.97 (0.96 to 0.99)
Mean current weight, kg, n=1062 23.3 (11 to 51) 1.01 (0.97 to 1.06)
Current height, cm, n=1057 119 (7) 1.00 (0.97 to 1.03)
Mean arm circumference, cm, n=1062 18.3 (2.4) 1.02 (0.95 to 1.08)
Number of current smokers in house
  0 546 (49) 0
  1 322 (29) 1.61 (1.22 to 2.12)
  ≥2 238 (22) 2.08 (1.71 to 2.54)
Municipality of residence PTREND <0.001
  Arroyo Naranjo 455 (41) 0
  Cerro 139 (13) 1.72 (1.61 to 1.84)
  Habana del Este 307 (28) 0.86 (0.84 to 0.88)
  La Lisa 205 (19) 1.24 (1.21 to 1.27)
  P=0.04
Current infection and blood assays
Helicobacter stool antigen +ve, n=756 11 (1) 1.45 (0.63 to 3.33)
Toxoplasmosis +ve, n=759 487 (64) 0.97 (0.70 to 1.34)
Mean log dengue IgG serology, n=758 1.67 (1.53) 0.95 (0.90 to 1.01)
Log CRP, n=757 −0.83 (1.41) 0.99 (0.86 to 1.15)
Mean log eosinophils, n=868 −1.62 (1.45) 1.02 (0.90 to 1.15)
Mean log IgE, n=759 4.51 (0.97) 1.27 (1.15 to 1.41)
Toxocariasis +ve, n=673 64 (9) 0.96 (0.70 to 1.33)
Any atopy* (n=857) 52 (6) 0.81 (0.43 to 1.53)
Results in bold font have a probability of <0.05.
CRP, C- reactive protein.
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Table 3 Association of exposures with FEV1
Total number=903 No (%, SD) FEV1, mL (95% CI)
Prior exposures
Any wheeze in first year of life 416 (46) −16 (−50 to 18)
Family history of asthma 510 (56) −23 (−89 to 43)
Attendance at nursery 141 (16) −48 (−149 to 53)
Paracetamol in first year of life 215 (24) 8 (−36 to 51)
Mean birth weight, N, kg (SD) n=901 3.32 (0.53) 43 (−19 to 104)
Mean birth height, cm (SD) 50 (2) 11 (5 to 18)
Breast feeding ≥4 months 503 (56) 18 (−65 to 101)
Age=1 year
Mean log IgE, n=456 3.44 (1.39) −19 (−50 to 12)
Mean log eosinophils, n=451 −2.14 (1.04) −13 (−56 to 30)
Age=2 years
Helicobacter stool +ve, n=589 29 (5) −78 (−270 to 115)
Age=3 years
Mean log CRP, SD, n=614 −2.16 (2.71) 2 (−9 to 12)
Log dengue IgG, n=545 −0.43 (2.00) 7 (−10 to 25)
Helicobacter stool +ve, n=775 51 (7) −39 (−132 to 54)
Mean log eosinophils, n=652 −1.78 (1.26) 22 (−5 to 49)
Toxoplasmosis serology +ve, n=606 362 (60) 48 (−46 to 143)
Mean log IgE, n=614 3.68 (1.57) 8 (−21 to 37)
Medical diagnosis of dengue infection 78 (9) −27 (−59 to 5)
Current exposures
Male sex 468 (52) 36 (−23 to 96)
Mean age (months), (range) 74 (64 –83) 4 (−12 to 21)
Wheeze in past 12 months 353 (39) −62 (−160 to 35)
Mean weight, kg, n=902 (range) 23.5 (11 –51) 11 (3 to 18)
Current height, cm, n=903 (range) 119 (90 –175) 8 (2 to 14)
Mean arm circumference, cm n=901 18.4 (2.4) 12 (1 to 24)
Number of current smokers in house
0 447 (49) 0
1 261 (29) 0 (−20 to 19)
≥2 195 (22) −39 (−108 to 30)
Municipality of residence
Arroyo Naranjo 371 (41) 0
Cerro 119 (13) 74 (31 to 117)
Habana del Este 247 (27) 048 (39 to 57)
La Lisa 166 (18) −95 (−126 to −64)
  P<0.001
Current infection and blood assays
Helicobacter stool antigen +ve, n=685 10 (1) −10 (−228 to 207)
Toxoplasmosis +ve, n=688 437 (64) 8 (−49 to 65)
Mean log dengue IgG serology, n=687 1.63 (1.56) −5 (−24 to 14)
Log CRP, n=686 −0.87 (1.38) −9 (−37 to 20)
Mean log eosinophils, n=785 −1.61 (1.47) −5 (−41 to 31)
Mean log IgE, n=688 4.52 (0.97) −12 (−87 to 63)
Continued
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Total number=903 No (%, SD) FEV1, mL (95% CI)
Toxocariasis +ve, n=667 57 (9) −15 (−125 to 95)
Any atopy* (n=818) 52 (6) −54 (−182 to 74)
adjusted for sex, age in months, 
current height and clustering by 
municipality
Results in bold font have a probability of <0.05.
* Any allergen skin prick test >3 mm larger than saline control.
CRP, C- reactive protein; FEV1, forced expiratory volume in 1 s.
Table 3 Continued
the recent changes in Cuba that have made it easier for 
the population more mobile, and hence many children 
left the policlinic from where they were initially recruited 
when their family moved their residence. There was only 
a small difference in the prevalence of wheeze in the first 
year of life between those who provided data at the age 
of 6 years (46%) and those who did not (42%), so loss 
to follow- up is unlikely to constitute a major source of 
bias. Collecting data on parental or self- reported wheeze 
using questionnaires is challenging, and although we 
used the optimal methodology from the ISAAC inter-
national studies of allergic disease18 it is possible that 
some of the cases of wheeze were not asthma. Similarly, 
parental reported asthma medication use may be prone 
to recall bias, although as acute asthma in children is 
an upsetting family event it is likely to be remembered 
accurately although the time period possibly less so. This 
included a number of health and lifestyle questions that 
were answered by the parent or guardian and particular 
attention was paid to parental/guardian reported wheeze 
in the past 12 months using the methodology developed 
for the ISAAC epidemiological studies of asthma,18 use 
of asthma medication in the past 12 months and expo-
sure to environmental tobacco smoke. There are no vali-
dated lung function normal values in Cuban children 
aged 6 years old and as a consequence we were unable 
to generate reliable per cent predicted values of the lung 
function in our study population. Finally, we used the 
200 mL as the definition of repeatability of FEV1, which 
is a value generally used in adults. As a consequence, 
our population provided FEV1 measures that will have 
a higher measurement error than observed in clinical 
patients. Nonetheless, these data of the peak FEV1 value 
records have an epidemiological value as the method-
ology of data collection was standardised across the whole 
population. This is supported by the observation of the 
association between FEV1 and height, which are both 
different aspects of somatic growth.
Like many cohorts, our study began as a cross- sectional 
population- based that aimed to explore causes of the 
high prevalence of asthma in Habana, Cuba. Further 
funding permitted this to become a prospective study, 
with a particular emphasis on infections found in the 
tropics. As a consequence, we have tested a variety of 
analyses and present the results in their entirety. While 
we recognise that it is possible to generate a number of 
papers analysing different hypotheses from these data, 
this approach has the advantage of presenting a complete 
body of work that hopefully can inform researchers who 
are interested in this area. While we have considered that 
sex and age in months are a priori confounding factors 
and adjusted for them in all analyses, we have refrained 
for searching through all the data to look for other 
possible confounding factors and possible interactions. 
The one exception to this is to explore the hypothesis that 
cigarette smoking may explain the differences observed 
between municipalities for wheeze, FEV1 and bronchodi-
latation as this is an obvious question that was driven by 
Cuban public health concerns about the hazards of expo-
sure to secondhand tobacco smoke.
risk factors for wheeze in the previous 12 months at 6 years 
old
Wheeze in the first year of life is associated with wheeze 
in later childhood,23 and may reflect the establishment 
of the asthmatic phenotype in susceptible children. The 
observation that paracetamol consumption in early life 
is associated with wheeze in later life24 has been noted 
before, and our data support these observations. However, 
they do not demonstrate a causality, as an alternative 
explanation is reverse causality with the administration of 
more paracetamol to children who are more susceptible 
to infections and wheeze.25
The observation that H. pylori at the age of 2 years, but 
not 3 years old or 6 years old is associated with lower risk 
of wheeze at 6 years old is an interesting observation, that 
would be consistent with the hypothesis that age of expo-
sure to infection is important. Data from other countries 
has demonstrated the Helicobacter is associated with lower 
rates of allergic disease but not wheeze in children,11 26 
but not in adults.27 It is striking however that our prev-
alence of H. pylori infection was very low at less than 7% 
in the first 6 years of life, suggesting that this may be less 
important in Cuba compared with other countries.11
From a public health perspective, exposure to cigarette 
smoking and the municipality of residence are the most 
important exposures for wheeze at the age of 6 years. 
Secondhand cigarette smoke exposure is well recognised 
as a risk factor for wheeze in children,5 and it is a concern 
that 51% of the homes in our study population contained 
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Table 4 Association of exposures with bronchodilatation after inhaled salbutamol
Total number=903 No (%, SD) % change in FEV1 (95% CI)
Prior exposures
Any wheeze in first year of life 417 (46) 1.94 (0.81 to 3.08)
Family history of asthma 510 (56) 1.85 (0.14 to 3.57)
Attendance at nursery 138 (15) −3.21 (−9.10 to 2.68)
Paracetamol in first year of life 213 (24) −0.67 (−4.68 to 3.35)
Mean birth weight, kg (SD) n=901 3.32 (0.53) −2.67 (−4.49 to −0.84)
Mean birth height, cm 50 (2) 0.06 (−0.56 to 0.69)
Breast feeding ≥4 months 503 (56) 0.61 (−2.87 to 4.09)
Age=1 year
Mean log IgE, n=455 3.42 (1.39) 1.68 (0.54 to 2.82)
Mean log eosinophils, n=449 −2.13 (1.04) −0.16 (−2.54 to 2.21)
Age=2 years
Helicobacter stool +ve, n=586 28 (5) −6.41 (−14.94 to 2.10)
Age=3 years
Mean log CRP, SD, n=615 −2.12 (2.71) −0.28 (−0.88 to 0.32)
Log dengue IgG, n=550 −0.43 (2.01) −0.38 (−1.50 to 0.74)
Helicobacter stool +ve, n=776 51 (6) −1.40 (−7.30 to 4.51)
Mean log eosinophils, n=653 −1.78 (1.26) −0.39 (−4.45 to 3.68)
Toxoplasmosis serology +ve, n=607 362 (60) −0.45 (−7.06 to 6.16)
Mean log IgE, n=615 3.68 (1.57) 0.23 (−1.81 to 2.27)
Medical diagnosis of dengue infection 78 (9) −0.58 (−8.55 to 7.38)
Current exposures
Male sex 466 (52) 2.22 (−0.28 to 4.71)
Age (months), (range) 74 (64– 83) −0.13 (−0.47 to 0.20)
Wheeze in past 12 months 353 (39) 3.61 (−5.80 to 13.02)
Mean current weight, kg, n=893 (range) 24 (11 –51) −0.23 (−0.54 to 0.08)
Current height, cm, n=893 119 (90– 175) −0.08 (−0.50 to 0.34)
Mean arm circumference, cm, n=893 18.4 (2.4) −0.14 (−0.81 to 0.54)
Number of current smokers in house
0 446 (49) 0
1 263 (29) −0.87 (−5.89 to 4.14)
≥2 194 (21) 2.93 (−3.80 to 9.65)
Municipality of residence
Arroyo Naranjo 368 (41) 0
Cerro 119 (13) −1.34 (−2.56 to −0.11)
Habana del Este 249 (28) −0.07 (−0.46 to 0.31)
La Lisa 167 (18) 6.24 (5.56 to 6.91)
  P=0.002
Current infection and blood assays
Helicobacter stool antigen +ve, n=684 10 (1) 8.89 (−9.17 to 26.96)
Toxoplasmosis +ve, n=687 438 (64) −0.47 (−3.34 to 2.39)
Mean log dengue IgG serology, n=686 1.64 (1.56) 0.30 (−1.44 to 2.03)
Log CRP, n=685 −0.87 (1.40) 0.37 (−1.64 to 2.38)
Mean log eosinophils, n=782 −161 1.47) 0.99 (−0.48 to 2.46)
Mean log IgE, n=686 4.52 (0.98) 0.64 (−0.18 to 1.45)
Continued
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Total number=903 No (%, SD) % change in FEV1 (95% CI)
Toxocariasis +ve, n=666 58 (9) −1.03 (−5.29 to 3.23)
Any atopy* (n=816) 52 (6) −2.75 (−10.15 to 4.60)
Adjusted for sex, age in months and clustering by municipality.
Results in bold font have a probability of <0.05.
*Any allergen skin prick test >3 mm larger than saline control.
CRP, C- reactive protein; FEV1, forced expiratory volume in 1 s.
Table 4 Continued
at least one smoker. The risk of wheeze was higher in 
the municipalities of Cerro and La Lisa, which suggest 
that there may be an environmental factor that predis-
poses to asthma symptoms such as higher levels of air 
pollution.28–30
risk factors for modified FeV1 at 6 years old
The fact that children living in La Lisa municipality 
already have lower lung function at the age of 6 years 
is a major public health concern, and suggests that an 
exposure associated with living in this area may negatively 
impact on lung growth. La Lisa had by far the highest 
increase in FEV1 after administration of aerosolised salbu-
tamol, suggesting that bronchoconstriction is contrib-
uting to the low baseline FEV1 and that a component of 
the apparent low lung function is reversible. La Lisa is 
located inland and while there is no obvious sources of 
excessive industrial pollution,30 and we speculate that 
this may be associated with higher levels of air pollution 
as a consequence of the relative absence of sea winds 
compared with the other municipalities. Weight, height 
and mean arm circumference were all positively associ-
ated with FEV1 at 6 years of age which is likely to be simply 
because they are all measures of somatic growth.
risk factors for bronchodilatation after inhaled salbutamol at 
6 years old
Wheeze in the first year of life was associated with bron-
chodilatation after the administration of inhaled salbu-
tamol at 6 years. This suggests that symptoms of asthma 
in early life are predictive of untreated bronchoconstric-
tion 5 years later, and is consistent with the hypothesis 
that the asthmatic phenotype can be observed to persist 
from early life onwards.23 The observation that birth 
weight is inversely associated with bronchoconstriction 
provides objective evidence to support the earlier epide-
miological evidence that adults with higher birth weights 
have a lower risk of having a diagnosis of asthma.16 The 
observation that a family history asthma is associated with 
bronchoconstriction also wheeze is consistent with the 
knowledge that there is a genetic component to asthma.31
self-reported wheeze and bronchoconstriction
One interesting observation from our data is that the 
wheeze in the past 12 months is not associated with 
either FEV1 or the change in FEV1 after administration 
of inhaled bronchodilator. Although it is possible that 
children who have had wheeze subsequently received 
asthma treatment, this lack of association between asthma 
symptoms and objective measures of asthma has been 
described previously.32 This supports that concept that 
wheeze and reversibility of FEV1 after administration of 
aerosolised salbutamol may measure different aspects of 
lung development and health.
Public health implications of these data
The current study was designed in response to clinical 
concerns that asthma was becoming a public health 
problem in Havana. These data support that hypothesis, 
and in particular identify that living in certain municipali-
ties may result in higher levels of currently unknown expo-
sures that require public health intervention. It is possible 
that environmental air pollution may drive some of these 
geographical differences, and that studies of air pollution 
are urgently required in Havana. The prevalence of expo-
sure to secondhand tobacco smoke in children living in 
Havana remains high, and this is an area where a combi-
nation of public health interventions including taxation, 
legislation that enforces bans of smoking in the work-
place and public places, restrictions on tobacco product 
advertising and helping individual smokers quit smoking 
are known to be effective. We are exploring these hypoth-
eses further by doing further objective measurements of 
particulate air pollution within the study population.
summary
Asthma is common in young children living in Havana, 
and the high prevalence of the use of systemic steroids 
probably reflects the underuse of regular inhaled cortico-
steroid prophylaxis treatments leading to the requirement 
for rescue treatment for wheezing. As societies urbanise, 
environmental air pollution may increase from a variety of 
sources. Cuba’s economy has been inversely affected due 
to historical and political events,33 and it remains under 
an economic embargo from the USA that has negatively 
impacted on healthcare.34 This makes providing regular 
inhaled corticosteroids to all children who need them 
challenging. However, other low- income and middle- 
income countries also have difficult economic and envi-
ronmental circumstances, and if these observations are 
replicated elsewhere, then this represents an important 
global public health issue.
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